- Trials with a EudraCT protocol (76)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
76 result(s) found for: Internal capsule.
Displaying page 1 of 4.
EudraCT Number: 2011-003168-63 | Sponsor Protocol Number: AMLSG16-10/CPKC412ADE02T | Start Date*: 2012-04-27 |
Sponsor Name:University Hospital Ulm | ||
Full Title: Phase-II study evaluating midostaurin in induction, consolidation and maintenance therapy also after allogeneic blood stem cell transplantation in patients with newly diagnosed acute myeloid leuk... | ||
Medical condition: Patients with confirmed diagnosis of AML or related precursor neoplasm, or acute leukemia of ambiguous lineage (classified according to the World Health Organization (WHO) 2008 classification) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002236-14 | Sponsor Protocol Number: BI1160.206 | Start Date*: 2015-10-28 |
Sponsor Name:University Hospital Ulm | ||
Full Title: Phenprocoumon versus Dabigatran in subjects with atrial fibrillation and left atrial thrombus - a prospective, randomized, controlled, open-label one year follow-up pilot study | ||
Medical condition: left atrial thrombus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-004463-39 | Sponsor Protocol Number: 221921 | Start Date*: 2019-03-06 |
Sponsor Name:Sahlgrenska University Hospital, Department of Internal Medicine/Respiratory Medicine and Allergology [...] | ||
Full Title: Influence on cough and airway symptoms by oral capsaicin (capscium oleoresin ) – a phase II, randomised, placebo-controlled clinical study in patients with chronic idiopathic cough | ||
Medical condition: Chronic idiopathic cough | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001845-15 | Sponsor Protocol Number: TINCRBEL_study | Start Date*: 2018-07-13 |
Sponsor Name:Academic medical centre, department of internal medicine | ||
Full Title: EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study) | ||
Medical condition: Chronic intestinal failuyre (IF) is caused by large surgical bowel resection, severe motility, or absorption diseorders. These patientds require partial or total parenteral nutrition (PN and TPN, r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000305-24 | Sponsor Protocol Number: AN01AC11 | Start Date*: 2021-03-18 |
Sponsor Name:Anebulo pharmaceuticals, Inc. | ||
Full Title: A randomized, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of CB1 antagonist ANEB-001 in healthy occasional ... | ||
Medical condition: THC intoxication | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001101-14 | Sponsor Protocol Number: 750253.01.030 | Start Date*: 2016-03-09 |
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | ||
Full Title: Driving fitness under acute and subchronic application of Silexan® (WS® 1265) in comparison to placebo and Lorazepam with healthy volunteers in two successive, randomized, double-blind, crossover d... | ||
Medical condition: Investigation in healthy volunteers. The investigational medicinal product has a marketing authorisation in Germany for the treatment of restlessness related to anxious mood. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004021-16 | Sponsor Protocol Number: FIM-PXE-2016-01 | Start Date*: 2018-10-31 | |||||||||||
Sponsor Name:Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS) | |||||||||||||
Full Title: Response to oral lansoprazole in inorganic pyrophosphate levels in patients with Grönblad-Stranberg disease (Pseudoxanthoma Elasticum) | |||||||||||||
Medical condition: Grönblad-Stranberg disease (Pseudoxanthoma Elasticum) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003187-31 | Sponsor Protocol Number: GN09CA403 | Start Date*: 2015-03-19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:NHS Greater Glasgow & Clyde | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Misoprostol for the Healing of Small Bowel Ulceration in Patients with Obscure Blood Loss while Taking Low-Dose Aspirin or Non-Steroidal Anti-inflammatory Drugs [MASTERS Trial] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Small bowel ulcers associated with iron deficiency anaemia or obscure blood loss in patients using aspirin or non-steroidal anti-inflammatory drugs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023409-37 | Sponsor Protocol Number: AMLSG_15-10 | Start Date*: 2011-03-02 |
Sponsor Name:University Hospital Ulm | ||
Full Title: Randomized Phase III Study of Low-Dose Cytarabine and Etoposide with or without All-Trans Retinoic Acid in Older Patients not Eligible for Intensive Chemotherapy with Acute Myeloid Leukemia and NPM... | ||
Medical condition: Adult patients (>60) with AML and NPM1 mutation ineligible for intensive chemotherapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005033-29 | Sponsor Protocol Number: CT/08.22 | Start Date*: 2009-07-20 |
Sponsor Name:Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete | ||
Full Title: A PHASE II STUDY OF sunitinib IN PATIENTS WITH ADVANCED HORMONE RESISTANT AND CHEMOTHERAPY RESISTANT PROSTATE CANCER. | ||
Medical condition: Patients with advanced hormone resistant and chemotherapy resistant prostate cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001960-28 | Sponsor Protocol Number: RCTVITD/SARS-CoV-19 | Start Date*: 2020-05-25 |
Sponsor Name:Investigation Institute Bioaraba | ||
Full Title: Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19) | ||
Medical condition: COVID-19 infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003635-46 | Sponsor Protocol Number: 05/MRE10/72 | Start Date*: 2006-05-16 |
Sponsor Name:NHS Lothian University, Research & Development | ||
Full Title: Do Anti-Oxidants Modulate the Outcome of Fractures? The Effect of Vitamin C on Functional Outcome Following Fracture of Distal Radius: A Prospective randomised controlled trial. | ||
Medical condition: Adult patients with fractures of the distal radius. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005163-29 | Sponsor Protocol Number: 05BFCH/Co04 | Start Date*: 2006-03-09 |
Sponsor Name:IBSA (Institut Biochimique SA) | ||
Full Title: “A multicentre, comparative, randomised, double-blind clinical trial on the equivalence of the efficacy and the safety of CHONDROSULF® 1200 mg, oral gel in sachet, once daily, versus CHONDROSULF® 4... | ||
Medical condition: Knee osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: Removed from public view |
EudraCT Number: 2015-001235-20 | Sponsor Protocol Number: 14.0189 | Start Date*: 2015-06-05 |
Sponsor Name:St George's University of London | ||
Full Title: Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease | ||
Medical condition: PARTICIPANTS WITH EVIDENCE OF CEREBRAL SMALL VESSEL DISEASE | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002217-22 | Sponsor Protocol Number: SJ-546 | Start Date*: 2016-09-02 | ||||||||||||||||
Sponsor Name:Sjællands University Hospital, Køge | ||||||||||||||||||
Full Title: Validation of stimulated ∆FGF19 for diagnosing bile acid diarrhoea | ||||||||||||||||||
Medical condition: Bile acid malabsorption / bile acid diarrhoea | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001617-27 | Sponsor Protocol Number: IVA_01_337_HSSC_15_001 | Start Date*: 2015-09-18 | ||||||||||||||||
Sponsor Name:Inventiva SAS | ||||||||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicentre proof-of-concept trial of IVA337 in the treatment of diffuse cutaneous systemic sclerosis | ||||||||||||||||||
Medical condition: Systemic sclerosis (scleroderma) (SSc) is a chronic connective tissue disorder of unknown aetiology characterized by widespread microvascular damage and excessive deposition of collagen in the skin... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) ES (Completed) GB (Completed) DE (Completed) NL (Completed) SI (Completed) BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005723-33 | Sponsor Protocol Number: amantadineSCEDI. | Start Date*: 2015-03-27 |
Sponsor Name:GGZ Oost Brabant | ||
Full Title: Efficacy of amantadine on behavioural and emotional problems and impairment of executive functioning due to acquired brain injury to the frontal lobes: a series of single case experimental design s... | ||
Medical condition: behavioural and emotional problems and impairment of executive functioning due to acquired brain injury to the frontal lobes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004249-17 | Sponsor Protocol Number: NCTU:6831 | Start Date*: 2014-02-12 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: A randomised, placebo controlled trial of extra-oesophageal reflux treatment in the management of upper respiratory symptoms. [TOPPITS: Trial of Proton Pump Inhibitors in Throat Symptoms] | ||
Medical condition: Persistent throat symptom - globus, hoarseness, throat clearing, throat discomfort, choking spasms, excess mucus/postnasal drip, otherwise unexplained night time cough of choking. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003284-39 | Sponsor Protocol Number: LEVOF_L_03815 | Start Date*: 2008-07-22 | |||||||||||
Sponsor Name:sanofi-aventis France | |||||||||||||
Full Title: Etude nationale, multicentrique, non comparative, évaluant l’efficacité de l’association lévofloxacine (500 mg) et rifampicine (600 ou 900 mg selon le poids) administrée une fois par jour par voie ... | |||||||||||||
Medical condition: infections sur prothèses ostéo-articulaires (IPOA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003620-20 | Sponsor Protocol Number: P101005 | Start Date*: 2013-06-04 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Tamsulosin to prevent the failures of early bladder catheter removal after acute urinary retention in elderly women hospitalized for an acute medical problem | |||||||||||||
Medical condition: urinary disorder | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
